期刊文献+

星点设计-效应面法优化紫杉醇自微乳给药系统 被引量:8

Optimization of self-microemulsifying drug delivery system for paclitaxel by central composite design-response surface method
下载PDF
导出
摘要 目的紫杉醇自微乳释药系统的制备优化及评价。方法通过溶解度试验、伪三元相图的绘制及星点设计-效应面法,以粒径、平衡溶解度和自乳化时间为指标,筛选最佳处方,并对紫杉醇自微乳的理化性质和体外释药进行测定。结果紫杉醇自微乳最佳处方:十四酸异丙酯为23.93%、聚氧乙烯蓖麻油为57.91%、聚乙二醇400为18.16%;其平均粒径<40 nm,自乳化时间<86 s。结论制得的紫杉醇自微乳给药系统稳定,能显著提高紫杉醇的溶解度。 Objective To optimize and assess the preparation of self-microemulsifying drug delivery system(SMEDDS) for paclitaxel. Methods The optimum formulation of paclitaxel SMEDDS was screened by solubility, tertiary phase diagrams and central composite design-response surface method, with the particle size, the balanced solubility and the time of self-emulsification as parameters. The physic-chemical property and dissolution characters of paclitaxel SMEDDS were also determined. Results The optimum self-microemulsifying drug delivery system was composed of IPM(23.93%), Cremophor EL(57.91%), and PEG-400(18.16%). The average partical size after the emulsification was less than 40 nm, the time of self-microemulsification was less than 86 s. Conclusion The prepared paclitaxel SMEDDS is stable, which can greatly increase the solubility of paclitaxel.
出处 《中南药学》 CAS 2014年第11期1069-1072,共4页 Central South Pharmacy
关键词 紫杉醇 自微乳 伪三元相图 星点设计 效应面法 paclitaxel self-microemulsion ternary phase diagram central composite design response surface method
  • 相关文献

参考文献15

  • 1Wani MC,Taylor HL,Wall ME,et al.Plant antitumor agents.VI.Isolation and structure of taxol,a novel antileukemic and antitumor agent from Taxus brevifolia[J].J Am Chem Soc,1971,93(9):2325-2327.
  • 2Rowinsky EK,Onetto N,Canetta RM,et al.Taxol:the first of the taxanes,an important new class of antitumor agents[C]//Smein Oncol,1992,19(6):646-662.
  • 3MalingréMM,Beijnen JH,Schellens JHM.Oral delivery of taxanes[J].Invest New Drug,2001,19(2):155-162.
  • 4Pouton CW.Lipid formulations for oral administration of drugs:non-emulsifying,self-emulsifying and‘selfmicroemulsifying’drug delivery systems[J].Eur J Pharm Sci,2000,11:S93-S98.
  • 5Pouton CW.Formulation of self-emulsifying drug delivery systems[J].Adv Drug Deliver Rev,1997,25(1):47-58.
  • 6Neslihan GR,Benita S.Self-emulsifying drug delivery systems(SEDDS)for improved oral delivery of lipophilic drugs[J].Biomed Pharmacother,2004,58(3):173-182.
  • 7中国药典2010年版.二部[S].2010:附录29.
  • 8潘国梁,贾晓斌,魏惠华,王勇.药用微乳伪三元相图的几种制备方法比较研究[J].中国药房,2006,17(1):21-23. 被引量:61
  • 9陆彬,张正全.用三角相图法研究药用微乳的形成条件[J].药学学报,2001,36(1):58-62. 被引量:83
  • 10Liu Y,Zhang P,Feng N,et al.Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin[J].Int J Pharmaceut,2009,365(1):136-142.

二级参考文献47

共引文献248

同被引文献73

  • 1姚静,周建平,杨宇欣,平其能.微乳对难溶性药物增溶机理的研究[J].中国药科大学学报,2004,35(6):495-498. 被引量:28
  • 2郝琨,柳晓泉,王广基.藤黄酸在大鼠体内的药代动力学[J].中国药科大学学报,2005,36(4):338-341. 被引量:18
  • 3Oerlemans C,Bult W,Bos M,et al.Polymeric micelles in anticancer therapy:targeting,imaging and triggered release[J].Pharm Res,2010,27(12):2569-2589.
  • 4Yokoyama M.Polymeric micelles as a new drug carrier system and their required considerations for clinical trials[J].Expert Opin Drug Deliv,2010,7(2):145-158.
  • 5Kabanov AV,Batrakova EV,Alakhov VY.Pluronic block copolymers for overcoming drug resistance in cancer[J].Adv Drug Deliv Rev,2002,54(5):759-779.
  • 6Damson S,Ferry D,Alakhov V,et al.PhaseⅠdose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin(SP1049C)in patients with advanced cancer[J].Br J Cancer,2004,90(11):2085-2091.
  • 7Gao ZG,Fain HD,Rapoport N.Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound[J].J Control Release,2005,102(1):203-222.
  • 8Lee ES,Na K,Bae YH.Polymeric micelle for tumor p H and folate-mediated targeting[J].J Control Release,2003,91(1-2):103-113.
  • 9El Kareh AW, l.abes RE, Secomb TW. Cell cycle checkpoint models for cellular pharmacology of paclitaxel and platinum drugs[J]. AAPSJ, 2008, 10(1): 15-34.
  • 10Malingr6 MM, Beijnen JH, Schellens JH. Oral delivery of taxanes[J]. Invest New Drugs, 2001, 19(2): 155-162.

引证文献8

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部